Moderna, Inc.
MRNA
Below: live stock price for Moderna, Inc. (MRNA), a 1-year chart, 8 indicators (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volume), and a compare mode. Add to your portfolio, star to your watchlist, or set a price alert in one place.
Moderna, Inc. (MRNA) trades at 145.43 USD on investpig.
- Prev close
- $150.81
- Volume (24h)
- $694.70M
- Market cap
- $58.06B
- Currency
- USD
Score
Insufficient data
- Value—
- Quality—
- Momentum—
- Growth—
- Risk—
- Dividend—
- Liquidity—
Composite of public market data. Informational only — not investment advice.
Trend projection
Where the recent trend points if it continues.
- +5 bars
- 153.5408 +5.58%
- +20 bars
- 165.4874 +13.80%
- +60 bars
- 170.3546 +17.14%
- +120 bars
- 170.5358 +17.27%
Linear-regression continuation — not a prediction, not investment advice. ±1σ ≈ 68% range · ±2σ ≈ 95% range: ±0.2844 USD.
Interpretation
Price sits near the upper third of the recent range, trend is sloping upward.
Descriptive observation — not investment advice.
Price report
How this asset has actually moved over the last 253 days.
Where the price sits between the window low and high.
- Volatility (annualised)
- 126.6%
- Max drawdown
- -34.2%
- Below period high
- -17.7%
- Best day
- +176.97%
- Worst day
- -23.55%
- Up days
- 52%
- Current streak
- 2 down
- Typical day swing
- 6.3%
- Volume vs average
- +508%
Spread of returns. Higher means larger swings in both directions.
Worst peak-to-trough fall inside the window.
Current price against the highest point in the window.
Share of days that closed above the one before.
Average high-to-low spread within a single day.
Last 10 days against the whole window.
Descriptive statistics over past prices — not a forecast and not investment advice.
Reference levels
Fibonacci retracements and extensions across the recent range.
Reference only — not investment advice.
These coordinates describe past-trade clustering, not where to buy or sell. Do your own research before any trade.
Levels derived from: 176.66 high → 45.67 low · 60 bars
- ResistanceFib +161.8% extensionnot reached388.6018 USD+167.22% from current
- ResistanceFib +100% extensionnot reached307.65 USD+111.55% from current
- ResistanceFib +61.8% extensionnot reached257.6118 USD+77.14% from current
- ResistanceFib +27.2% extensionnot reached212.2893 USD+45.98% from current
- ResistanceFib 23.6% retracementNearesttested 8×145.7464 USD+0.22% from current
- Current145.425 USD
- SupportFib 38.2% retracementtested 1×126.6218 USD-12.93% from current
- SupportFib 50% midpointnot reached111.165 USD-23.56% from current
- SupportFib 61.8% retracementnot reached95.7082 USD-34.19% from current
- SupportFib 78.6% retracementtested 5×73.7019 USD-49.32% from current
- SupportFib −27.2% extensionnot reached10.0407 USD-93.10% from current
- SupportFib −61.8% extensionnot reached-35.2818 USD-124.26% from current
- SupportFib −100% extensionnot reached-85.32 USD-158.67% from current
How to read this
We take the highest and lowest price of the last 60 bars and cut the gap between them at the classic Fibonacci ratios (23.6%, 38.2%, 50%, 61.8%, 78.6%), plus extensions beyond both ends.
“Tested N×” counts how many of those 60 bars actually traded through the level. A level price has crossed many times is one the market has repeatedly agreed on; a level at 0 is pure geometry the price has never reached.
This is a map of where trading has already happened — not a forecast and not a signal. Price moves through these levels all the time.
Recent news
- Evercore ISI Adjusts Moderna Price Target to $80 From $50, Maintains In Line RatingMT Newswires1h ago
- Rothschild & Co Redburn Downgrades Moderna to Sell From Neutral, Adjusts PT to $81 From $40MT Newswires5h ago
- This Fund Bought Moderna Before It Nearly Tripled. See Its 2 New Stock PicksInsider Monkey20m ago
- Broadcom upgraded, Ultragenyx downgraded: Wall Street's top analyst callsThe Fly1h ago
- Jim Cramer Explains Why Heavily Shorted Moderna (MRNA) Has Room to RunInsider Monkey17h ago
- Here Are Thursday’s Top Wall Street Analyst Research Calls: Broadcom, Deere & Company, Dell Technologies, Devon Energy, Moderna, Permian Resources, PG&E, Thermo Fisher, Viper Energy, and More24/7 Wall St.3h ago
- GSK to Advance mRNA Influenza Vaccine Into Phase III DevelopmentZacks23h ago
- Typewriter raises $56m Series A to progress non-viral gene therapy platformPharmaceutical Technology3h ago
Related
Other assets in this category.
- 8306.TMitsubishi UFJ Financial Group, Inc.3,754 USD+1.90%
- 7203.TToyota Motor Corporation3,117 USD-0.51%
- 9984.TSoftBank Group Corp.5,001 USD+1.56%
- 6758.TSony Group Corporation3,895 USD-0.64%
- 6861.TKeyence Corporation77,980 USD-0.05%
- NVDANVIDIA Corporation226.22 USD+0.81%
- AAPLApple Inc.328.995 USD+1.24%
- GOOGLAlphabet Inc.341.6 USD+1.33%
Live discussion
Sign in to join the discussion.
- No comments yet. Be the first.